Condition
Neonatal Sepsis, Late-Onset
Total Trials
6
Recruiting
2
Active
3
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Recruiting2
Unknown1
Completed1
Active Not Recruiting1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07585188Not ApplicableNot Yet Recruiting
Neonatal Catheter Lock for Infection Prevention
NCT06772675Not ApplicableRecruiting
Vancomycin Reduction Practices (VRP) in the NICU
NCT07248761Phase 4Active Not Recruiting
Early Hydrocortisone Versus Regular Treatment in Shock in Extremely Preterm Neonates - an Open Randomized Controlled Trial
NCT07152106Recruiting
Amniotic Fluid & the Preterm Gut
NCT05763680Unknown
Molecular Culture for the Diagnosis of Neonatal Sepsis
NCT04867135CompletedPrimary
Population Pharmacokinetics of Amikacin in Neonates
Showing all 6 trials